Try from €1.50 / week
A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC
Dublin-headquartered Horizon pharmaceutical has agreed to buy Hyperion Therapeutics for $1.1bn (€1bn) to gain drugs to treat rare metabolic diseases, adding to this year’s surge in pharmaceutical- industry takeovers.
Tue, 31 Mar, 2015
News
Tuesday, October 21, 2025 - 4:00 PM
Tuesday, October 21, 2025 - 10:00 AM
Tuesday, October 21, 2025 - 6:00 PM